Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Authors

Keywords

Journal

Volume 27, Issue 9, Pages 1432-1439

Publisher

American Society of Clinical Oncology (ASCO)

Online

2009-02-18

DOI

10.1200/jco.2008.19.0108

References

View 4 related references

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now